Remove clinical digestive-health
article thumbnail

Mayo Clinic, Ayble Health Team Up Make GI Care Less Complicated

MedCity News

Digital health platform Ayble Health partnered with Mayo Clinic to offer patients a hybrid care model for digestive health that matches them with the appropriate virtual and in-person services based on their acuity and needs. The hybrid care model is available for large employers and health plans.

Patients 117
article thumbnail

Enhancing Patient Care: 4 Strategies for Life Sciences Companies

Salesforce

Life sciences leaders are taking note, recognizing the need to incorporate health consumers’ perspectives when it comes to product and therapy development. A recent survey found that Asian, black, and Hispanic respondents were nearly twice as likely as white respondents to have never heard of clinical research.

Patients 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Issues That Matter Most in 2023: Medical Metaverse

Eversana Intouch

It’s especially important in categories adopting metaverse efforts early, such as mental health (PTSD, anxiety, depression), neurology (ADHD, MS, pain management), and procedure-driven specialties like surgery. We release a monthly digest of medical metaverse news. We release a monthly digest of medical metaverse news.

Medical 52
article thumbnail

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Likelihood of Approval

Pharmaceutical Technology

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Chondrosarcoma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama.

article thumbnail

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Likelihood of Approval

Pharmaceutical Technology

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Chondrosarcoma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama.

article thumbnail

Healthware forms new medical communications division

pharmaphorum

Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division. “Since the beginning, our goal at Healthware has always been to improve the lives of HCPs and patients.

Medical 96
article thumbnail

GoodRx Surpasses $500M in Savings for Americans with Diabetes

PM360

By offering invaluable access to affordable diabetes medicines and glucose monitors, accurate and digestible information about treatment options, and thorough research on diabetes and insulin prices, GoodRx is making it easier for people to afford their medications and adhere to their treatment plans. 1 The Lancet estimates that “more than 1.31

Doctors 72